Le Lézard
Classified in: Health
Subject: SBS

Maqui Berry and Omega-3 Fish Oil Make O3+Maquitm Completely Unique


FORT LAUDERDALE, Fla., Oct. 29, 2020 /PRNewswire/ -- Focus Laboratories brings their science-based formulas and product innovation to every aspect of their business. From ingredients to design, Focus Laboratories was founded on the principle of doing things in their own unique way. Though the company has worked on many different types of ocular health products since its founding, its latest product, O3+Maquitm, has so far been one of their most promising developments yet.

Combining two powerful nutritional elements into one pill, O3+Maquitm dietary supplements are made using the patented Unigeltm Technology, which combines a liquid and a powder tablet into one softgel. While some supplements are best when taken as a powder, others, like the Omega-3 fatty acid in O3+Maquitm are best taken in their liquid form. By finding a way to put two supplements together into one pill, Focus Laboratories is changing the way supplements are developed and consumed.

Focus Laboratories began as a research and development company aimed at promoting better ocular health, though the company recently changed gears to begin working on a new avenue for promoting ocular and total body health via the dietary supplemental health market.  O3+Maquitm is the premiere supplement in the product assortment, and it is already receiving rave reviews from both the supplemental health community and Focus Laboratories' customer base. O3+Maquitm is the perfect hybrid of specialized supplement use, addressing specific concerns and more general, holistic health.

Their O3+Maquitm softgels have a full 100mg of their star ingredient, MaquiBright®.   MaquiBright ® is the purified extract of the Maqui Berry, a deep purple berry that has been used medicinally by the native people of Chile for centuries. Maqui berries only grow in a few distinct regions and have recently been researched as a "superfood" for their antioxidant properties.

But not only is Maqui Berry the latest addition to the superfood family, but it may also be the greatest. Maqui berry has been tested to contain more antioxidant power than similar counterparts, like blueberry, or even acai. The rich purple pigment of the berry is actually a signifier of the intensity of its antioxidant strength, and the purple color remains a prominent feature of the O3+Maquitm.

The combination of Omega-3 fish oil and powdered Maqui Berry extract work synergistically, creating a more powerful supplement when taken together. But besides using MaquiBright ®, Focus Laboratories utilizes a high-quality fish oil to ensure that their dietary supplements work as intended.

O3+Maquitm is a supplement unlike any other, combining two powerhouse ingredients to create a completely new experience. Focus Laboratories' O3+Maquitm supplements are currently for sale through their company website, as well as major online retailers, including Amazon.com, with more available on the way as they expand their brand reach in the coming year.

Please direct inquiries to:
Rochester Alvarez
(954) 769-2267
[email protected]

SOURCE Focus Laboratories


These press releases may also interest you

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:00
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings. SONIFI Health is a leading U.S. healthcare technology company based in Sioux...

at 17:00
A record 3,618 graduating students and physicians matched to residency training programs in Canada in this year's R-1 Main Residency Match (R-1 match), the Canadian Resident Matching Service (CaRMS) announced today....

at 16:54
Hondros College of Nursing (HCN) will introduce a new Medical Assisting program at its six Ohio campuses in 2024 to meet the growing need for medical assistants in a variety of settings.  According to the U.S. Bureau of Labor Statistics (BLS),...

at 16:45
Halozyme Therapeutics, Inc. ("Halozyme") today announced the election of Mahesh Krishnan, M.D. to its Board of Directors. Dr. Krishnan has more than 20 years of experience in healthcare, biotechnology and health services. "Mahesh is a dynamic and...



News published on and distributed by: